A total of 37 original research projects from aspiring physician-scientists were on display at the 2018 Medical Student Research Forum.


UB’s Summer Research Fellowship Program, which provides first-year medical students with a personalized experience in research, has been renewed through another five years of funding from the National Institutes of Health.


Anthony A. Campagnari, PhD ’84, senior associate dean for research and graduate education, has received the 2016 Stockton Kimball Award for outstanding scientific achievement and service.


Michael W. Russell, PhD, has co-edited and co-written the fourth edition of the only comprehensive reference on mucosal immunology’s basic science and clinical manifestations.


In the fight against infectious disease, University at Buffalo immunologist Michael W. Russell, PhD, professor of microbiology and immunology, advocates a novel alternative to antibiotics and vaccines: directly target the immune system.

For-Robin, a company founded and led by a Kate Rittenhouse-Olson, PhD, will further study and develop a promising potential cancer treatment.
Research led by a student in UB’s Medical Scientist Training Program is featured on the cover of the world’s most frequently cited cancer journal.

Nearly 100 student-scientists from across the country showcased their original biomedical research during the 2014 Buffalo Summer Research Day.


Lee Ann Garrett-Sinha, PhD, associate professor of biochemistry, has been named an associate editor of The Journal of Immunology.

University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).

With the ultimate goal of designing new immunotherapeutic strategies, Richard B. Bankert, VMD, PhD, professor of microbiology and immunology, and his team are working to re-activate cancer-killing T cells in a tumor’s microenvironment.


Through her fledgling start-up firm, University at Buffalo researcher Kate Rittenhouse-Olson, PhD ’84, is turning a mouse antibody she created into a promising cancer-fighting therapy for humans.


Researchers in the Department of Microbiology and Immunology have developed a new way to stimulate an immune response to gonorrhea.


More than 100 student scientists from across the country showcased their original research during this summer’s University at Buffalo Biomedical Research Day.


Richard B. Bankert, VMD, PhD, professor in the Department of Microbiology and Immunology, and Zhen Yan, PhD, professor in the Department of Physiology and Biophysics, have received 2013 SUNY Chancellor’s Awards for Excellence.


The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.


Researchers have discovered a new vaccine target for tuberculosis using a UB-patented adjuvant that boosts the potency of mucosal vaccines.


Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.


UB researchers have identified specific roles for two innate immune pathways that drive acute lung injury—findings that may lead to the first treatment or preventive strategy for the condition.


UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.